scholarly article | Q13442814 |
P2093 | author name string | Xiao-xing Wang | |
Hui-min Yan | |||
Zhuo-wei Hu | |||
Xiao-xi Lv | |||
Zi-yan Wang | |||
Han-zhi Liu | |||
Jia-ping Wang | |||
Xiao-ming Fu | |||
P2860 | cites work | Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation | Q77753940 |
Inflammation and atherosclerosis | Q80015206 | ||
Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice | Q80805032 | ||
Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome | Q80819961 | ||
Targeting TLR2 attenuates pulmonary inflammation and fibrosis by reversion of suppressive immune microenvironment | Q83089214 | ||
TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production | Q85005541 | ||
Toll-like receptor signalling | Q24570126 | ||
Toll-like receptor-2 mediates diet and/or pathogen associated atherosclerosis: proteomic findings | Q27300289 | ||
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data | Q28242645 | ||
TLR signaling | Q28291637 | ||
Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress | Q29615495 | ||
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE | Q29620722 | ||
Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP. | Q30488194 | ||
Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events | Q33318184 | ||
Modulation of atherosclerosis in mice by Toll-like receptor 2 | Q34063165 | ||
Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice. | Q34342389 | ||
Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress | Q34346809 | ||
TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. | Q35041384 | ||
Endogenous ligands of Toll-like receptors | Q35792678 | ||
Toll-like receptor signaling and atherosclerosis | Q36433507 | ||
Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. | Q36459911 | ||
Multiple roles of Toll-like receptor signaling in atherosclerosis | Q36589015 | ||
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists | Q36811131 | ||
Mouse models for atherosclerosis and pharmaceutical modifiers. | Q36836487 | ||
Innate immunity, macrophage activation, and atherosclerosis | Q36938635 | ||
Molecular mechanisms of plaque instability | Q36947974 | ||
The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis | Q37065920 | ||
Progression and disruption of advanced atherosclerotic plaques in murine models | Q37108304 | ||
Immune and inflammatory mechanisms of atherosclerosis (*) | Q37325024 | ||
Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress | Q37401270 | ||
Endoplasmic reticulum stress increases the expression and function of toll-like receptor-2 in epithelial cells. | Q39646441 | ||
Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4. | Q40255422 | ||
Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses. | Q41862930 | ||
Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis | Q42641324 | ||
The endoplasmic reticulum stress-C/EBP homologous protein pathway-mediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques. | Q42961940 | ||
Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development | Q46380675 | ||
Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice | Q47320668 | ||
Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. | Q53606830 | ||
Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse | Q73295343 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | atherosclerosis | Q12252367 |
P304 | page(s) | 1025-1035 | |
P577 | publication date | 2013-07-15 | |
P1433 | published in | Acta Pharmacologica Sinica | Q15749885 |
P1476 | title | Blocking TLR2 activity diminishes and stabilizes advanced atherosclerotic lesions in apolipoprotein E-deficient mice | |
P478 | volume | 34 |